A Randomized Phase 2 Study of Gataparsen in Combination With Docetaxel Versus Docetaxel Alone in Hormone Refractory Prostate Cancer.
Phase of Trial: Phase II
Latest Information Update: 01 Mar 2014
At a glance
- Drugs Gataparsen (Primary) ; Docetaxel; Prednisone
- Indications Prostate cancer
- Focus Adverse reactions; Biomarker; Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 04 Jun 2013 Results presented at the 49th Annual Meeting of the American Society of Clinical Oncology.
- 21 Nov 2012 New source identified and integrated (German Clinical Trials Register: DRKS00004130).
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History